Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients

Clinical trial NCT06696794 · RECRUITING

Trial details

NCT number: NCT06696794
Sponsor: Shaogang Wang
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Muscle-Invasive Bladder Cancer (NMIBC)

Start date: 2025-02-17
Primary completion: 2027-06-30
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.